Cargando...
Ondansetron Exposure Changes in a Pregnant Woman
Pregnancy results in many physiologic changes that can alter the pharmacokinetic profiles of medications used during pregnancy. One of the primary factors leading to these pharmacokinetic changes is altered activity of drug-metabolizing enzymes. Ondansetron is a substrate of cytochrome P450 (CYP) 3A...
Gardado en:
| Publicado en: | Pharmacotherapy |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5738660/ https://ncbi.nlm.nih.gov/pubmed/27374186 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.1796 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|